so NWBO in its last 10Q was lying when it said this:
The Company has completed a Phase 3 clinical trial of its DCVax®-L product for glioblastoma braincancer , has publicly reported the results in a peer reviewed publication in a medical journal as well as at a medical conference, and is working on prerequisites and preparations for filing an application for regulatory approval of the product.
So in their last 10Q NWBO said they were working on preparations for filing an application for approval of the product FOR glioblastoma braincancer
But according to you thats nonsense in reality, they are working application to be approved on a Tissue Agnostic basis?